Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA

Detalles Bibliográficos
Autores principales: Liang, J-H, Wang, L, Peter Gale, R, Wu, W, Xia, Y, Fan, L, Li, J-Y, Xu, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637107/
https://www.ncbi.nlm.nih.gov/pubmed/29016569
http://dx.doi.org/10.1038/bcj.2017.88
_version_ 1783270571274928128
author Liang, J-H
Wang, L
Peter Gale, R
Wu, W
Xia, Y
Fan, L
Li, J-Y
Xu, W
author_facet Liang, J-H
Wang, L
Peter Gale, R
Wu, W
Xia, Y
Fan, L
Li, J-Y
Xu, W
author_sort Liang, J-H
collection PubMed
description
format Online
Article
Text
id pubmed-5637107
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56371072017-10-16 Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA Liang, J-H Wang, L Peter Gale, R Wu, W Xia, Y Fan, L Li, J-Y Xu, W Blood Cancer J Letter to the Editor Nature Publishing Group 2017-09 2017-09-15 /pmc/articles/PMC5637107/ /pubmed/29016569 http://dx.doi.org/10.1038/bcj.2017.88 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Liang, J-H
Wang, L
Peter Gale, R
Wu, W
Xia, Y
Fan, L
Li, J-Y
Xu, W
Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
title Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
title_full Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
title_fullStr Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
title_full_unstemmed Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
title_short Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
title_sort efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/t-cell lymphoma with the analysis of the prognosis of whole blood ebv-dna
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637107/
https://www.ncbi.nlm.nih.gov/pubmed/29016569
http://dx.doi.org/10.1038/bcj.2017.88
work_keys_str_mv AT liangjh efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT wangl efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT petergaler efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT wuw efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT xiay efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT fanl efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT lijy efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna
AT xuw efficacyofpegaspargaseetoposidemethotrexateanddexamethasoneinnewlydiagnosedadvancedstageextranodalnaturalkillertcelllymphomawiththeanalysisoftheprognosisofwholebloodebvdna

Ejemplares similares